Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 94,600 | 42,194 | 161,579 | 63,866 | 60,849 |
| Accounts receivable | N/A | N/A | 41,067 | N/A | N/A |
| Other Working Capital | 8,636 | 16,967 | 36,402 | 90,846 | 93,172 |
| Other Operating Activity | -7,344 | 17,457 | 2,317 | 56,680 | 37,652 |
| Operating Cash Flow | $95,891 | $76,618 | $241,365 | $211,392 | $191,672 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -118,298 | -107,975 | -87,960 | -99,122 | -100,529 |
| PPE Investments | -7,651 | -4,750 | N/A | -10,548 | -5,893 |
| Purchase Sale Intangibles | N/A | N/A | -13,445 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -13,445 | 0 | 0 |
| Investing Cash Flow | $-125,949 | $-112,725 | $-101,405 | $-109,669 | $-106,422 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,712 | 3,027 | 32,645 | 32,901 | 28,657 |
| Other Financing Activity | -23,403 | -24,134 | 0 | 0 | 0 |
| Financing Cash Flow | $-13,690 | $-21,107 | $32,645 | $32,901 | $28,657 |
| Exchange Rate Effect | 2,061 | -7,303 | -14,550 | -11,471 | -6,724 |
| Beginning Cash Position | 215,742 | 222,480 | 46,637 | 48,510 | 45,409 |
| End Cash Position | 174,055 | 157,964 | 204,692 | 171,662 | 152,592 |
| Net Cash Flow | $-41,687 | $-64,516 | $158,055 | $123,153 | $107,183 |
| Free Cash Flow | |||||
| Operating Cash Flow | 95,891 | 76,618 | 241,365 | 211,392 | 191,672 |
| Capital Expenditure | -7,651 | -4,750 | N/A | -10,548 | -5,893 |
| Free Cash Flow | 88,240 | 71,868 | 241,365 | 200,845 | 185,779 |